Skip to main content
SpringerLink
Log in

Hormone replacement therapy and improved survival among postmenopausal women diagnosed with colon cancer (USA)

  • Published:
Cancer Causes & Control Aims and scope Submit manuscript

Abstract

Objectives: Hormone replacement therapy (HRT) has been inversely associated with colon cancer incidence in several epidemiologic studies. In this study we used data from a population-based incident case–control study of colon cancer to evaluate the role of HRT use in survival after diagnosis with colon cancer.

Methods: Data from 815 postmenopausal women living in Utah, California, and Minnesota diagnosed between 1 September 1991 and 30 September 1994 were used to examine associations between HRT and survival.

Results: After adjusting for age at time of diagnosis, stage of disease at time of diagnosis, study center, and body mass index (BMI), we observed that women who had ever used HRT had a 30% lesser probability of dying of any cause and a 40% lower probability of dying from colon cancer specifically during the follow-up period. Further evaluation by years of HRT use showed that those who had used HRT for 4 or more years had the lowest risk of dying of colon cancer (hazard rate ratio 0.5, 95% confidence interval 0.3–0.9). Evaluation of other lifestyle variables with HRT use did not show significant confounding or effect modification.

Conclusions: These findings suggest that HRT use may improve short-term survival after diagnosis with colon cancer; there is no suggestion that HRT use is detrimental to survival.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Wingo PA, Ries LA, Rosenberg HM, Miller DS, Edwards BK (1998) Cancer incidence and mortality, 1973–1995. Cancer 82: 1197-1207.

    Google Scholar 

  2. Potter JD, Slattery ML, Bostick RM, Gasptur SM (1993) Colon cancer: a review of the epidemiology. Epidemiol Rev 15: 499-545.

    Google Scholar 

  3. Slattery ML, French TK, Egger MJ, Lyon JL (1989) Diet and survival of patients with colon cancer in Utah: is there an association? Int I Epidemiol 18: 792-797.

    Google Scholar 

  4. Selby JV, Friedman GD, Quesenberry CP, Weiss NS (1992) A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 326: 653-657.

    Google Scholar 

  5. Jacobs EJ, White E, Weiss NS (1994) Exogenous hormones, reproductive history, and colon cancer (Seattle, Washington, USA). Cancer Causes Control 5: 359-366.

    Google Scholar 

  6. Newcomb PA, Storer BE (1995) Postmenopausal hormone use and risk of large-bowel cancer. J Natl Cancer Inst 87: 1067-1071.

    Google Scholar 

  7. Hebert-Croteau N (1998) A meta-analysis of hormone replacement therapy and colon cancer in women. Cancer Epidemiol Biomarkers Prev 7: 653-660.

    Google Scholar 

  8. Potter JD, Bostick RM, Grandits GA, Fosdick L, Elmer P, Wood J, Grambsch P, Louis TA (1996) Hormone replacement therapy is associated with lower risk of adenomatous polyps of the large bowel: the Minnesota Cancer Prevention Research Unit Case-Control Study. Cancer Epidemiol Biomarkers Prev 10: 779-784.

    Google Scholar 

  9. Everson GT, McKinley C, Kern F (1991) Mechanisms of gallstone formation in women. Effects of exogenous estrogen and dietary cholesterol on hepatic lipid metabolism. J Clin Invest 87: 237-246.

    Google Scholar 

  10. Lointier P, Wildrick DM, Boman BM (1992) The effects of steroid hormones on a human colon cancer cell line in vitro. Anticancer Res 12: 1327-1330.

    Google Scholar 

  11. Issa JPJ, Ottaviano YL, Celano P, et al. (1994) Methylation of the estrogen receptor CpG island links aging and neoplasia in human colon. Nature Genet 7: 536-540.

    Google Scholar 

  12. Potter JD (1995) Hormones and colon cancer. J Natl Cancer Inst 87: 1039-1040.

    Google Scholar 

  13. Kampman E, Potter JD, Slattery ML, Caan BJ, Edwards S (1997) Hormone replacement therapy, reproductive history, and colon cancer: a multicenter, case-control study in the United States. Cancer Causes Control 8: 146-158.

    Google Scholar 

  14. Edwards SL, Slattery ML, Mori M, et al. (1994) Objective system for interviewer performance evaluation for use in epidemiologic studies. Am J Epidemiol 140: 1020-1028.

    Google Scholar 

  15. Slattery ML, Caan BJ, Duncan D, Berry TD, Coates A, Kerber R (1994) A computerized diet history questionnaire for epidemiologic studies. J Am Diet Assoc 94: 761-766.

    Google Scholar 

  16. Criqui MH, Suarez L, Barrett-Connor E, McPhillips J, Wingard DL, Garland C (1988) Postmenopausal estrogen use and mortality. Results from a prospective study in a defined, homogeneous community. Am J Epidemiol 128: 606-614.

    Google Scholar 

  17. Ettinger B, Friedman GD, Bush T, Quesenberry CP Jr (1996) Reduced morality associated with long-term postmenopausal estrogen therapy. Obstet Gynecol 87: 6-12.

    Google Scholar 

  18. Henderson BE, Paganini-Hill A, Ross RK (1991) Decreased mortality in users of estrogen replacement therapy. Arch Intern Med 151: 75-78.

    Google Scholar 

  19. Grodstein F, Stampher MJ, Colditz GA et al. (1997) Postmenopausal hormone therapy and mortality. N Engl J Med 336: 1769-1775.

    Google Scholar 

  20. Singh S, Paraskeva C, Gallimore PH, et al. (1994) Differential growth response to oestrogen of premalignant and malignant colonic cell lines. Anticancer Res 14: 1037-1042.

    Google Scholar 

  21. Maminta MLD, Molteni A, Rosen ST (1991) Stable expression of the human estrogen receptor in HeLa cells by infection: effect of estrogen on cell proliferation and c-myc expression. Mol Cell Endocrinol 78: 61-69.

    Google Scholar 

  22. Tutton PJM, Barkla DH (1982) Differential effects of estrogenic hormones on cell proliferation in the epithelium and colonic carcinomata of rats. Anticancer Res 2: 199-202.

    Google Scholar 

  23. Holli K, Isola J, Cuzick J (1998) Low biologic aggressiveness in breast cancer in women using hormone replacement therapy. J Clin Oncol 16: 3115-3120.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. School of Medicine, University of Utah, Salt Lake City, Utah, 84108, USA

    Martha L. Slattery, Wade Samowitz, Sandra L. Edwards & Karen Curtin

  2. School of Public Health, University of Minnesota, Minneapolis, Minnesota, USA

    Kristin Anderson

  3. Kaiser Permanente Medical Care Program, Oakland, California, USA

    Bette Caan

  4. Fred Hutchinson Cancer Center, Seattle, Washington, DC, USA

    John D. Potter

Authors
  1. Martha L. Slattery
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kristin Anderson
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Wade Samowitz
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sandra L. Edwards
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Karen Curtin
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Bette Caan
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. John D. Potter
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Slattery, M.L., Anderson, K., Samowitz, W. et al. Hormone replacement therapy and improved survival among postmenopausal women diagnosed with colon cancer (USA). Cancer Causes Control 10, 467–473 (1999). https://doi.org/10.1023/A:1008974215622

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1008974215622

Search

Navigation